Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers
CA 2501131 A1 · Owner: Teh, Bin Tean · Inventors: Teh, Bin Tean; Takahashi, Masayuki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Genes that are differentially expressed in subtypes of renal cell carcinomas are disclosed as are their polypeptide products. This information is utilized to produce nucleic acid and antibody probes and sets of such probes that are specific for these genes and their products. Methods employing these probes including hybridization and immunological methods are used to determine the , subtype of a renal cell tumor sample from a subject based on the differential expression of such genes that is characteristic of the cancer subtype.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 6, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.